Capital Flow Monitor · Sponsors · CIK 1805698
EIKONOKLASTES THERAPEUTICS, INC.
2356 PARK AVENUE, CINCINNATI, OH, 45206 · (513) 549-6484
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$15.8M
Sold
$13.6M
% sold
86.0%
Investors
14
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-29 | D ·current | 506(b) | $15.8M | $13.6M | 86.0% | 14 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Bruce Halpryn — Executive Officer / Director, Cincinnati, OH
- Samuel Lee — Executive Officer / Director, Cincinnati, OH
- Kenneth Morand — Director, Cincinnati, OH
- Thomas Finn — Director, Cincinnati, OH
- Robert Johnson — Director, Cincinnati, OH
- Joseph Nolan — Director, Cincinnati, OH
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.